Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Integrated Freight and Logistics

Cryoport, Inc. provides cryogenic logistics solutions to the life sciences industry. The Company designs and manufactures temperature-sensitive and cryogenic packaging systems for the shipping of biological items. Cryoport also offers a proprietary logistics management platform that manages ordering, tracking, paperwork, customs documentation, and communications.
Website: cryoport.com


  • Bad financial results growth rate -11.2% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-21.5%)
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 31.6% (LTM)
  • Share price is 114.0% higher than minimum and 61.1% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (500.0x vs 30.0x)
  • For the last 3 months insiders sold company shares on $0.2 mln (-0.050% of cap.)

Key Financials (Download financials)

Ticker: CYRX
Share price, USD:  (+0.9%)10.06
year average price 7.67  


year start price 7.84 2024-12-12

min close price 4.70 2025-03-10

max close price 10.76 2025-10-24

current price 10.06 2025-12-11
Common stocks: 50 257 112

Dividend Yield:  0.0%
EV / Sales: 1.6x
Margin (EBITDA LTM / Revenue): -137.4%

Target EV / EBITDA (hist percentile): 30.0x
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 506
Net Debt ($m): -183
EV (Enterprise Value): 323
EBITDA LTM (млн $): -279
Price to Book: 1.0x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2025-12-02seekingalpha.com

Cryoport: Picks And Shovels For The Gene Therapy Boom

2025-11-04seekingalpha.com

Cryoport, Inc. (CYRX) Q3 2025 Earnings Call Transcript

2025-11-04zacks.com

CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates

2025-10-17zacks.com

CryoPort (CYRX) Moves 7.0% Higher: Will This Strength Last?

2025-08-05seekingalpha.com

Cryoport, Inc. (CYRX) Q2 2025 Earnings Call Transcript

2025-08-05zacks.com

CryoPort, Inc. (CYRX) Reports Q2 Loss, Tops Revenue Estimates

2025-06-27zacks.com

CryoPort (CYRX) Upgraded to Buy: Here's What You Should Know

2025-05-07seekingalpha.com

Cryoport, Inc. (CYRX) Q1 2025 Earnings Call Transcript

2025-03-31seekingalpha.com

Cryoport, Inc. (CYRX) Strategic Agreement and Transaction with DHL Group Call (Transcript)

2025-03-31prnewswire.com

DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-12 2024-11-07 2024-08-08 2024-05-08 2024-03-13 2023-11-09 2023-08-09 2023-05-04 2023-02-28 2022-11-04
acceptedDate 2025-11-06 14:33:28 2025-08-11 21:57:47 2024-11-07 16:56:56 2024-08-08 14:55:32 2024-05-07 19:03:52 2024-03-13 17:26:29 2023-11-09 14:18:41 2023-08-09 16:47:13 2023-05-04 17:22:22 2023-02-28 17:08:32 2022-11-04 15:14:03
calendarYear 2024 2024 2023 2023 2023 2022 2022 2022 2022 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
revenue 44M 45M 57M 58M 55M 57M 56M 57M 63M 60M 60M
costOfRevenue 23M 24M 31M 37M 33M 39M 32M 32M 36M 34M 34M
grossProfit 21M 21M 25M 21M 22M 19M 24M 25M 27M 26M 26M
grossProfitRatio 0.482 0.47 0.448 0.363 0.399 0.326 0.432 0.434 0.431 0.435 0.437
researchAndDevelopmentExpenses 5M 4M 4M 5M 5M 5M 5M 4M 4M 5M 4M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 27M 27M 38M 31M 38M 34M 36M 39M 33M 33M 30M
otherExpenses 0 0 0 -1M 1M 5M -3M -704 000 4M 2M 0
operatingExpenses 31M 31M 42M 36M 43M 38M 41M 43M 37M 37M 34M
costAndExpenses 54M 55M 73M 73M 76M 77M 73M 75M 73M 71M 68M
interestIncome 3M 0 0 0 0 3M 3M 3M 0 0 0
interestExpense 526 000 618 000 889 000 1M 1M 1M 1M 1M 2M 1M 2M
depreciationAndAmortization 6M 7M 8M 8M 7M 54 880 -3M 7M 4M 2M 7M
ebitda 410 000 -4M 10M -69M -12M -12M -20M -12M -6M -9M -349 000
ebitdaratio 0.009 -0.084 0.18 -0.128 -0.228 -0.213 -0.356 -0.216 -0.096 -0.152 -0.006
operatingIncome -10M -10M -16M -15M -21M -20M -17M -18M -10M -11M -8M
operatingIncomeRatio -0.225 -0.212 -0.29 -0.259 -0.39 -0.343 -0.301 -0.321 -0.16 -0.183 -0.129
totalOtherIncomeExpensesNet 3M -2M 18M 2M 4M -44M 5M 2M 5M 3M 3M
incomeBeforeTax -7M -12M 1M -78M -19M -64M -13M -18M -5M -8M -5M
incomeBeforeTaxRatio -0.148 -0.258 0.026 -1.347 -0.342 -1.113 -0.228 -0.311 -0.081 -0.132 -0.087
incomeTaxExpense 165 000 274 000 649 000 383 000 215 000 -1M 471 000 635 000 492 000 1M 57 000
netIncome -7M 105M 805 000 -78M -19M -62M -13M -18M -6M -9M -5M
netIncomeRatio -0.157 2.314 0.014 -1.354 -0.346 -1.09 -0.236 -0.322 -0.089 -0.156 -0.088
eps -0.178 2.05 -0.024 -1.58 -0.39 -1.27 -0.27 -0.38 -0.12 -0.19 -0.11
epsdiluted -0.178 2.05 -0.024 -1.58 -0.39 -1.27 -0.27 -0.38 -0.12 -0.19 -0.11
weightedAverageShsOut 50M 50M 49M 49M 49M 49M 49M 49M 48M 49M 49M
weightedAverageShsOutDil 50M 50M 49M 49M 49M 49M 49M 49M 48M 49M 49M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30
symbol CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-12 2024-11-07 2024-08-08 2024-05-08 2024-03-13 2023-11-09 2023-08-09 2023-05-04 2023-02-28 2022-11-04
acceptedDate 2025-11-06 14:33:28 2025-08-11 21:57:47 2024-11-07 16:56:56 2024-08-08 14:55:32 2024-05-07 19:03:52 2024-03-13 17:26:29 2023-11-09 14:18:41 2023-08-09 16:47:13 2023-05-04 17:22:22 2023-02-28 17:08:32 2022-11-04 15:14:03
calendarYear 2024 2024 2023 2023 2023 2022 2022 2022 2022 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 243M 36M 45M 46M 50M 46M 59M 67M 39M 37M 31M
shortTermInvestments 183M 208M 228M 381M 399M 410M 406M 437M 484M 487M 499M
cashAndShortTermInvestments 426M 244M 273M 427M 449M 457M 466M 505M 523M 523M 530M
netReceivables 33M 28M 43M 40M 41M 42M 43M 43M 46M 44M 44M
inventory 23M 23M 24M 24M 25M 26M 29M 29M 26M 28M 25M
otherCurrentAssets 7M 116M 11M 11M 11M 10M 12M 9M 10M 9M 11M
totalCurrentAssets 489M 411M 350M 502M 526M 535M 549M 585M 605M 604M 609M
propertyPlantEquipmentNet 120M 120M 118M 116M 117M 118M 107M 99M 102M 90M 83M
goodwill 19M 21M 54M 52M 108M 108M 149M 149M 152M 151M 147M
intangibleAssets 144M 145M 176M 178M 190M 194M 193M 195M 188M 191M 192M
goodwillAndIntangibleAssets 162M 166M 230M 231M 298M 303M 342M 344M 340M 342M 340M
longTermInvestments 0 0 0 0 -758 001 0 0 0 0 0 0
taxAssets 267 000 614 000 2M 2M 758 000 656 000 863 000 934 000 937 000 947 000 2M
otherNonCurrentAssets 2M 2M 1M 2M 2M 2M 2M 1M 1M 1M 926 000
totalNonCurrentAssets 284M 289M 351M 350M 417M 423M 452M 445M 443M 435M 425M
otherAssets 0 0 0 0 0 1 0 0 0 0 0
totalAssets 774M 700M 702M 852M 943M 958M 1 001M 1 031M 1 048M 1 039M 1 034M
accountPayables 15M 13M 0 25M 27M 27M 28M 26M 26M 28M 0
shortTermDebt 4M 18M 6M 20M 6M 6M 5M 4M 4M 4M 4M
taxPayables 0 0 0 0 0 0 0 0 0 0 0
deferredRevenue 2M 2M 1M 1M 2M 1M 2M 927 000 1M 439 000 549 000
otherCurrentLiabilities 9M 40M 54M 14M 14M 12M 10M 9M 10M 8M 36M
totalCurrentLiabilities 30M 74M 61M 60M 49M 46M 45M 40M 42M 41M 41M
longTermDebt 224M 224M 227M 385M 409M 380M 409M 436M 436M 432M 430M
deferredRevenueNonCurrent 0 0 0 28M 0 30M 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 985 000 878 000 4M 3M 2M 3M 5M 5M 5M 5M 3M
otherNonCurrentLiabilities 3M 2M 0 5M 10M 10M 5M 5M 5M 5M 433M
totalNonCurrentLiabilities 228M 227M 230M 392M 422M 423M 418M 446M 446M 442M 437M
otherLiabilities 0 0 -9M 0 0 0 0 0 0 0 0
capitalLeaseObligations 43M 43M 0 33M 34M 30M 35M 33M 32M 29M 26M
totalLiabilities 259M 301M 283M 452M 471M 469M 463M 486M 488M 483M 478M
preferredStock 38M 36M 32M 30M 28M 26M 24M 22M 20M 18M 16M
commonStock 50 000 50 000 49 000 49 000 49 000 49 000 49 000 49 000 48 000 48 000 49 000
retainedEarnings -668M -769M -738M -739M -661M -642M -580M -567M -548M -543M -504M
accumulatedOtherComprehensiveIncomeLoss -5M -16M -16M -29M -30M -26M -34M -34M -30M -35M -43M
othertotalStockholdersEquity 1 151M 1 147M 1 141M 1 138M 1 135M 1 131M 1 127M 1 123M 1 118M 1 115M 1 086M
totalStockholdersEquity 515M 399M 419M 400M 472M 489M 538M 544M 561M 556M 556M
totalEquity 515M 399M 419M 400M 472M 489M 538M 544M 561M 556M 556M
totalLiabilitiesAndStockholdersEquity 774M 700M 702M 852M 943M 958M 1 001M 1 031M 1 048M 1 039M 1 034M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 774M 700M 702M 852M 943M 958M 1 001M 1 031M 1 048M 1 039M 1 034M
totalInvestments 183M 208M 228M 381M 399M 410M 406M 437M 484M 487M 499M
totalDebt 229M 243M 233M 405M 415M 416M 414M 441M 440M 436M 434M
netDebt -15M 207M 189M 358M 365M 370M 354M 374M 401M 399M 403M
link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2022 q2
date 2025-09-30 2025-06-30 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30
symbol CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX CYRX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-12 2024-11-07 2024-08-08 2024-05-08 2024-03-13 2023-11-09 2023-08-09 2023-05-04 2023-02-28 2022-11-04 2022-08-04
acceptedDate 2025-11-06 14:33:28 2025-08-11 21:57:47 2024-11-07 16:56:56 2024-08-08 14:55:32 2024-05-07 19:03:52 2024-03-13 17:26:29 2023-11-09 14:18:41 2023-08-09 16:47:13 2023-05-04 17:22:22 2023-02-28 17:08:32 2022-11-04 15:14:03 2022-08-04 17:04:07
calendarYear 2024 2024 2023 2023 2023 2022 2022 2022 2022 2022 2022 2022
period Q3 Q2 Q3 Q2 Q1 Q4 Q3 Q2 Q1 Q4 Q3 Q2
netIncome -7M -12M 805 000 -78M -19M -62M -13M -18M -6M -9M -5M -9M
depreciationAndAmortization 6M 7M 8M 8M 7M 7M 7M 7M 6M 6M 6M 5M
deferredIncomeTax -299 000 1M 639 000 -471 000 -551 000 -2M -3M 2M 246 000 70 000 0 0
stockBasedCompensation 0 0 5M 5M 5M 6M 6M 6M 5M 5M 5M 5M
changeInWorkingCapital -1M -10M 4M -6M 2M 4M 34 000 -1M -2M -2M -5M -17M
accountsReceivables -2M -7M -3M 1M 437 000 3M -16 000 3M -1M 4M -4M -8M
inventory -421 000 638 000 284 000 1M 1M 3M -325 000 -2M 1M -3M -2M -2M
accountsPayables -129 000 -2M -728 000 -3M 264 000 -3M -60 000 -1M -3M -2M 0 0
otherWorkingCapital 1M -2M 7M -5M -89 000 1M 435 000 -300 000 1M -1M 612 000 -4M
otherNonCashItems 4M 6M -17M 84M 2M 49M 2M 2M -1M 4M 253 000 0
netCashProvidedByOperatingActivities 2M -7M 447 000 -8M -3M 2M -2M -4M 3M 4M 982 000 -7M
investmentsInPropertyPlantAndEquipment -4M -6M -1M -6M -5M -12M -11M -11M -10M -8M -6M -5M
acquisitionsNet 0 210M 0 0 0 -7M 0 0 0 4M -4M 0
purchasesOfInvestments 0 0 -2M -36M -14M -43M 0 0 -2M -8M -19M -106M
salesMaturitiesOfInvestments 19M 26M 164M 55M 25M 48M 30M 45M 8M 24M 23M 49M
otherInvestingActivites 0 0 -6M 17M 977 000 4M 27M 0 2M -4M 0 -2M
netCashUsedForInvestingActivites 14M 230M 154M 13M 6M -15M 19M 34M -1M 7M -6M -64M
debtRepayment -146 000 -15M -155M -9M -106 000 -124 000 -25M -50 000 -31 000 -1M -1M -644 000
commonStockIssued 1M 3M -627 000 9000 618 000 -2000 180 000 1M 92 000 2M 0 0
commonStockRepurchased -4M -4M 0 0 0 -2000 0 0 0 -5M 0 -25M
dividendsPaid 0 0 0 0 -2M -8M 0 0 -2M -4M 0 0
otherFinancingActivites 0 0 21 000 9000 3M 34M 180 000 -10000 2M 2M 999 000 284 000
netCashUsedProvidedByFinancingActivities -3M -16M -155M -9M 512 000 -126 000 -25M 1M 71 000 -5M -459 000 -25M
effectOfForexChangesOnCash -1M 484 000 -519 000 263 000 -375 000 -723 000 499 000 -2M 481 000 399 000 -968 000 -1M
netChangeInCash 12M 207M -2M -3M 3M -13M -8M 29M 2M 6M -6M -97M
cashAtEndOfPeriod 256M 243M 45M 46M 50M 46M 59M 67M 39M 37M 31M 37M
cashAtBeginningOfPeriod 243M 36M 46M 50M 46M 59M 67M 39M 37M 31M 37M 134M
operatingCashFlow 2M -7M 447 000 -8M -3M 2M -2M -4M 3M 4M 982 000 -7M
capitalExpenditure -3M -4M -1M -6M -5M -12M -11M -11M -10M -8M -6M -5M
freeCashFlow -1M -12M -1M -14M -8M -10M -13M -15M -7M -5M -5M -12M
link Link Link Link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link Link Link Link

Earning call transcript

2025 q3
2025-11-04 ET (fiscal 2025 q3)
2025 q2
2025-08-05 ET (fiscal 2025 q2)
2025 q1
2025-05-07 ET (fiscal 2025 q1)
2024 q4
2025-03-04 ET (fiscal 2024 q4)
2024 q3
2024-11-09 ET (fiscal 2024 q3)
2024 q2
2024-08-06 ET (fiscal 2024 q2)
2024 q1
2024-05-07 ET (fiscal 2024 q1)
2023 q4
2024-03-12 ET (fiscal 2023 q4)
2023 q3
2023-11-09 ET (fiscal 2023 q3)
2023 q2
2023-08-09 ET (fiscal 2023 q2)
2023 q1
2023-05-05 ET (fiscal 2023 q1)
2022 q4
2023-02-23 ET (fiscal 2022 q4)
2022 q3
2022-11-05 ET (fiscal 2022 q3)
2022 q2
2022-08-06 ET (fiscal 2022 q2)
2022 q1
2022-05-07 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-10-29 12:30 ET
Cryoport to Report Third Quarter 2024 Financial Results on November 7, 2024
2024-10-22 12:30 ET
Cryoport and Gulf Coast Regional Blood Center Launch Strategic Alliance to Enhance Cellular Therapy Services
2024-10-21 12:30 ET
TMRW Life Sciences and Cryoport Systems Form Strategic Partnership to Elevate Standards for Frozen Egg, Embryo, and Sperm Offsite Storage and Biologistics
2024-10-15 12:30 ET
VGXI Selects Cryoport for Biostorage, Bioservices and Supply Chain Solutions to Advance Next-Generation Therapies
2024-10-07 12:30 ET
Cryoport Launches its IntegriCell™ Cryopreservation Solution with Opening of New Facility at its Houston Campus
2024-09-25 12:30 ET
SK pharmteco and Cryoport Partner for Cell and Gene Therapy Logistics and BioServices
2024-08-06 20:15 ET
Cryoport Reports Second Quarter 2024 Financial Results
2024-08-06 20:05 ET
Cryoport Announces $200 Million Repurchase Program and the Repurchase of $160 Million of Convertible Senior Notes
2024-07-23 12:30 ET
Cryoport to Report Second Quarter 2024 Financial Results on August 6, 2024
2024-06-20 12:30 ET
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
2024-05-07 20:08 ET
Cryoport Reports First Quarter 2024 Financial Results
2024-04-30 12:30 ET
Cryoport to Report First Quarter 2024 Financial Results on May 7, 2024
2024-03-12 20:05 ET
Cryoport Reports Fourth Quarter and Full Year 2023 Financial Results
2024-02-27 13:30 ET
Cryoport to Report Fourth Quarter and Full Year 2023 Financial Results on March 12, 2024
2023-11-27 13:30 ET
Cryoport and NIPPON EXPRESS HOLDINGS Form Global Strategic Partnership for Temperature-Controlled Supply Chain Services
2023-11-16 13:30 ET
Cryoport's CRYOPDP Expands U.S. Footprint with Acquisition of Bluebird Express
2023-11-08 21:05 ET
Cryoport Reports Third Quarter 2023 Financial Results
2023-11-02 12:30 ET
Cryoport Continues its Expansion in the European Market with Tec4med Lifescience GmbH Acquisition
2023-10-25 12:30 ET
Cryoport to Report Third Quarter 2023 Financial Results on November 8, 2023
2023-10-12 12:30 ET
Cryoport Inks New Multi-Year Supply Chain Solutions Agreement with Monash IVF
2023-10-10 12:30 ET
Cryoport and Cell and Gene Therapy Catapult Announce Strategic Collaboration at Stevenage Manufacturing Innovation Centre for Advancement of Cell and Gene Therapies
2023-10-09 20:05 ET
Be The Match BioTherapies® and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies
2023-09-14 12:30 ET
Cryoport Receives 2023 IMAPAC Asia Pacific Cell & Gene Therapy Excellence Award
2023-08-09 20:05 ET
Cryoport Reports Second Quarter 2023 Financial Results
2023-08-02 12:30 ET
Cryoport to Report Second Quarter 2023 Financial Results on August 9, 2023
2023-07-12 20:05 ET
Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations
2023-06-29 12:39 ET
IVFAustralia Selects Cryoport as Exclusive Supply Chain Solutions Provider
2023-05-04 20:05 ET
Cryoport Reports First Quarter 2023 Results
2023-04-27 12:30 ET
Cryoport to Report First Quarter 2023 Financial Results on May 4, 2023
2023-04-25 12:30 ET
Cryoport Signs New Supply Chain Solutions Agreement with Boston IVF to Support Reproductive Material Shipments Across the U.S.
2023-03-28 12:30 ET
Cryoport Announces Multi-Year Agreement with Inception Fertility
2023-03-13 10:00 ET
Cryoport Confirms No Financial Exposure to Silicon Valley Bank
2023-03-08 18:15 ET
Cell Therapy Has Shown Near Miraculous Remission Rates In Cancer Patients, But The Growing Industry Relies On This Company – A Uniquely Positioned Ticker In The Weeds?
2023-02-23 21:05 ET
Cryoport Reports Fourth Quarter and Full Year 2022 Results
2023-02-15 13:30 ET
Cryoport to Report Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
2023-01-18 13:30 ET
Cryoport Announces New Strategic Partnership with Syneos Health to Advance Cell & Gene Therapies
2022-12-20 13:30 ET
Cryoport to Present at the J.P. Morgan 41st Annual Healthcare Conference
2022-11-03 20:05 ET
Cryoport Reports Results for the Third Quarter 2022
2022-10-27 12:30 ET
Cryoport to Report Third Quarter 2022 Financial Results on November 3, 2022
2022-09-08 12:30 ET
Cryoport Enters into Strategic Relationship with Takeda's BioLife Plasma Services
2022-08-04 20:05 ET
Cryoport Reports Results for the Second Quarter 2022
2022-07-28 12:30 ET
Cryoport to Report Second Quarter 2022 Financial Results on August 4, 2022
2022-05-05 20:05 ET
Cryoport Reports First Quarter 2022 Results
2022-04-28 12:30 ET
Cryoport to Report First Quarter 2022 Financial Results on May 5, 2022
2022-04-18 12:30 ET
Cryoport Acquires Cell&Co BioServices
2022-03-30 21:00 ET
Cryoport's MVE Biological Solutions' New Prague Manufacturing Plant Returns to Full Production
2022-03-11 20:40 ET
Cryoport Authorizes $100 Million Repurchase Program
2022-02-24 21:05 ET
Cryoport Reports Fourth Quarter and Full Year 2021 Results
2022-02-15 13:30 ET
Cryoport Report's Fourth Quarter and 2021 Financial Results on February 24, 2022
2022-02-09 14:29 ET
Cryoport Provides Positive Update on MVE Biological Solution's New Prague Facility
2022-01-31 22:35 ET
Cryoport Reports Fire Damage at MVE's New Prague Facility
2022-01-27 13:30 ET
Cryoport and Cell Matters Enter into Strategic Partnership
2022-01-05 13:30 ET
Cryoport to Present at the J.P. Morgan 40th Annual Healthcare Conference
2021-11-10 05:20 ET
Cryoport, Inc. Prices Registered Direct Placement of Common Stock
2021-11-10 05:20 ET
Cryoport, Inc. Prices Upsized $350.0 Million Convertible Senior Notes Offering
2021-11-08 21:33 ET
Cryoport, Inc. Announces Proposed Convertible Senior Notes Offering
2021-11-08 21:29 ET
Cryoport, Inc. Announces Proposed Registered Direct Placement of Common Stock
2021-11-04 20:05 ET
Cryoport Reports Record Third Quarter and Nine Months Revenue for 2021
2021-10-29 14:30 ET
CRYOPDP, a Cryoport Company, Receives 2021 Europe Bioprocessing Excellence Award from IMAPAC
2021-10-28 20:15 ET
Cryoport to Report Third Quarter 2021 Financial Results on November 4, 2021
2021-08-25 12:15 ET
Cryoport and Mitsubishi Logistics Corporation Partner to Bring Temperature-Controlled Supply Chain Solutions to Asia-Pacific
2021-08-05 20:05 ET
Cryoport Reports Record Second Quarter 2021 Revenue
2021-07-29 12:30 ET
Cryoport to Report Second Quarter 2021 Financial Results on August 5, 2021
2021-06-22 12:30 ET
Cellenkos® Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need
2021-05-19 11:30 ET
Cryoport Further Expands its Asia Pacific Operations with New Global Logistics Center in Singapore
2021-05-18 11:30 ET
Cryoport Expands Global Supply Chain Network with Belgium Acquisition
2021-05-06 12:30 ET
LabConnect and Cryoport Partner to Provide Support for Innovative Triumvira Cell and Gene Therapy Clinical Trial
2021-05-04 20:05 ET
Cryoport Revenue Climbs to $53.3 Million for First Quarter 2021
2021-04-27 12:30 ET
Cryoport to Report First Quarter 2021 Financial Results on May 4, 2021
2021-04-06 12:30 ET
Cryoport Acquires Temperature-Controlled Logistics Provider in Australia
2021-03-03 21:08 ET
Cryoport Announces Appointment of Linda Baddour to its Board of Directors
2021-03-01 21:13 ET
Cryoport Reports Record Results for Full Year 2020
2021-02-25 13:45 ET
Cryoport to Report Fourth Quarter and Fiscal Year 2020 Financial Results on March 1, 2021
2021-02-25 13:15 ET
Cryoport Launches Environmental, Social, and Governance (ESG) Program
2021-02-08 13:00 ET
Blackstone Converts $51 million of Cryoport Series C Preferred Stock Into Common Stock
2021-01-25 17:22 ET
Cryoport Announces Closing of Public Offering of Common Stock and Full Exercise by Underwriters to Purchase Additional Shares
2021-01-21 03:30 ET
Cryoport Announces Pricing of Public Offering of Common Stock
2021-01-19 22:02 ET
Cryoport Announces Proposed Public Offering of Common Stock
2020-12-08 13:30 ET
Cryoport and CCRM Fertility Enter Into Agreement
2020-11-05 21:05 ET
Cryoport Reports 2020 Third-Quarter Results
2020-10-29 18:15 ET
Cryoport to Report Third Quarter 2020 Financial Results on November 5, 2020
2020-10-01 16:49 ET
Cryoport Completes Acquisitions of MVE Biological Solutions and CRYOPDP
2020-08-25 11:00 ET
Cryoport Announces Agreement to Acquire MVE Biological Solutions from Chart Industries
2020-08-21 11:30 ET
Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP
2020-08-06 20:05 ET
Cryoport Reports 2020 Second-Quarter Results
2020-08-04 12:30 ET
MEDIPAL HOLDINGS Partners with CRYOPORT to Bring Temperature-Controlled Supply Chain Solutions to the Japanese Market
2020-08-03 20:10 ET
Cryoport to Report Second Quarter 2020 Financial Results on August 6, 2020
2020-05-21 11:00 ET
Cryoport, Inc. Prices $100.0 Million Convertible Senior Notes Offering
2020-05-19 22:54 ET
Cryoport, Inc. Announces Proposed Convertible Senior Notes Offering
2020-05-07 20:05 ET
/C O R R E C T I O N -- Cryoport, Inc./
2020-04-30 12:30 ET
Cryoport to Report First Quarter 2020 Financial Results on May 7, 2020
2020-03-05 21:05 ET
Cryoport Reports Record Revenue for Fiscal Year 2019
2020-02-27 13:30 ET
Cryoport to Report Fourth Quarter and Fiscal Year 2019 Financial Results on March 5, 2020
2020-02-26 13:30 ET
Cryoport and Inception Fertility Enter Into Agreement
2019-11-05 14:00 ET
Lonza Partners with Cryoport and Strengthens its 'Vein-to-vein' Delivery Network in Cell & Gene Therapy
2019-10-31 12:30 ET
Cryoport to Report Third Quarter 2019 Financial Results on November 7, 2019
2019-10-09 13:00 ET
Cryoport Authorizes Share Repurchase Program and Presenting at Upcoming Investor Conferences
2019-09-18 12:30 ET
Cryoport Introduces Cell & Gene Industry's First Dedicated Shipper for Advanced Therapies
2019-08-08 20:05 ET
Cryoport Revenue Grows 83% for Second Quarter 2019
2019-07-25 12:30 ET
Cryoport to Report Second Quarter 2019 Financial Results on August 8th, 2019
2019-07-11 12:30 ET
Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain
2019-06-20 01:02 ET
Cryoport Announces Pricing of Public Offering of Common Stock
2019-06-19 20:03 ET
Cryoport Announces Proposed Public Offering of Common Stock
2019-06-05 12:30 ET
Cryoport to Ring the Nasdaq Closing Bell on Monday, June 10 and Attend Jefferies 2019 Healthcare Conference June 4  -7  , 2019
2019-05-14 21:22 ET
Cryoport Expands into Biostorage through the Acquisition of Cryogene
2019-05-02 20:05 ET
Cryoport Revenue Grows 65% for First Quarter 2019
2019-04-25 12:30 ET
Cryoport to Report First Quarter 2019 Financial Results on May 2nd, 2019
2019-04-11 12:30 ET
Celularity Selects Cryoport's Temperature Controlled Logistics Solutions
ET
Cryoport Continues to Set New Benchmarks for the Global Regenerative Medicine Supply Chain
ET
Cryoport Reports Third Quarter 2024 Financial Results
ET
Cryoport Expands IntegriCell™ Cryopreservation Services Solution with Opening of New Center of Excellence in Europe
ET
Cryoport's MVE Biological Solutions Registers All Manufacturing Facilities with the U.S. Food and Drug Administration ("FDA")
ET
Moffitt Cancer Center and Cryoport Announce Strategic Collaboration
ET
Cryoport Unveils State-of-the-Art Cryogenic Shipping System for Transporting Lifesaving Biologics and Temperature-Sensitive Therapies
ET
Cryoport to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025
ET
Cryoport Reports Fourth Quarter and Full Year 2024 Financial Results
ET
Cryoport's MVE Biological Solutions Expands High-Efficiency Cryogenic Freezer Series With Answer to Evolving Needs of Fertility Clinics, Biorepositories and Clinical Laboratories
ET
Cryoport to Host Investor Call to Discuss Recent Strategic Agreement and Transformative Transaction Today, March 31, 2025, at 8:30 a.m. ET
ET
DHL Group acquires CRYOPDP from Cryoport to strengthen "DHL Health Logistics"
ET
Cryoport to Report First Quarter 2025 Financial Results on May 7, 2025
ET
Cryoport Reports First Quarter 2025 Financial Results
ET
Cryoport Completes CRYOPDP Divestiture and Commences Strategic Partnership with DHL Group
ET
Cryoport's MVE Biological Solutions Introduces Next Generation Vapor Shippers
ET
Cryoport to Report Second Quarter 2025 Financial Results on August 5, 2025
ET
Cryoport Reports Second Quarter 2025 Financial Results
ET
Cryoport Systems Expands Global Footprint with New Global Supply Chain Center in Paris, France
ET
MVE Biological Solutions, A Cryoport Company, Introduces Real-Time Integrated Condition Monitoring Systems For Cryogenic Dewars
ET
Cryoport to Report Third Quarter 2025 Financial Results on November 4, 2025

SEC forms

Show financial reports only

SEC form 10
2025-11-06 14:33 ET
CryoPort reported for 2025 q3
SEC form 8
2025-11-04 17:18 ET
CryoPort published news for 2025 q3
SEC form 8
2025-11-04 17:18 ET
CryoPort reported for 2025 q3
SEC form 10
2025-08-12 01:57 ET
CryoPort published news for 2025 q2
SEC form 8
2025-08-05 21:39 ET
CryoPort published news for 2025 q2
SEC form 8
2025-08-05 21:39 ET
CryoPort reported for 2025 q2
SEC form 8
2025-06-13 19:55 ET
CryoPort published news for 2025 q1
SEC form 8
2025-06-13 19:55 ET
CryoPort published news for 2025 q1
SEC form 8
2025-06-13 19:55 ET
CryoPort published news for 2025 q1
SEC form 10
2025-05-08 21:18 ET
CryoPort published news for 2025 q1
SEC form 10
2025-05-08 00:00 ET
CryoPort published news for 2025 q1
SEC form 8
2025-05-07 20:16 ET
CryoPort published news for 2025 q1
SEC form 8
2025-05-07 20:16 ET
CryoPort reported for 2025 q1
SEC form 8
2025-03-31 12:17 ET
CryoPort published news for 2024 q4
SEC form 8
2025-03-31 12:17 ET
CryoPort published news for 2024 q4
SEC form 8
2025-03-31 12:17 ET
CryoPort published news for 2024 q4
SEC form 8
2025-03-31 12:17 ET
CryoPort published news for 2024 q4
SEC form 10
2025-03-07 22:02 ET
CryoPort published news for 2024 q4
SEC form 10
2025-03-07 00:00 ET
CryoPort published news for 2024 q4
SEC form 8
2025-03-04 17:07 ET
CryoPort published news for 2024 q4
SEC form 8
2025-03-04 17:07 ET
CryoPort reported for 2024 q4
SEC form 10
2024-11-07 16:56 ET
CryoPort reported for 2024 q3
SEC form 8
2024-11-07 16:31 ET
CryoPort published news for 2024 q3
SEC form 8
2024-11-07 16:31 ET
CryoPort published news for 2024 q3
SEC form 10
2024-08-08 00:00 ET
CryoPort published news for 2024 q2
SEC form 8
2024-08-06 17:17 ET
CryoPort published news for 2024 q2
SEC form 8
2024-08-06 17:17 ET
CryoPort reported for 2024 q2
SEC form 10
2024-05-08 00:00 ET
CryoPort published news for 2024 q1
SEC form 10
2024-05-07 19:03 ET
CryoPort published news for 2024 q1
SEC form 8
2024-05-07 16:53 ET
CryoPort published news for 2024 q1
SEC form 8
2024-05-07 16:53 ET
CryoPort reported for 2024 q1
SEC form 10
2024-03-13 17:26 ET
CryoPort published news for 2023 q4
SEC form 10
2024-03-13 00:00 ET
CryoPort published news for 2023 q4
SEC form 8
2024-03-12 16:30 ET
CryoPort published news for 2023 q4
SEC form 8
2024-03-12 16:30 ET
CryoPort reported for 2023 q4
SEC form 10
2023-11-09 00:00 ET
CryoPort published news for 2023 q3
SEC form 8
2023-11-08 16:31 ET
CryoPort reported for 2023 q3
SEC form 6
2023-08-09 17:28 ET
CryoPort published news for 2023 q2
SEC form 10
2023-08-09 16:47 ET
CryoPort reported for 2023 q2
SEC form 10
2023-08-09 00:00 ET
CryoPort published news for 2023 q2
SEC form 8
2023-08-09 00:00 ET
CryoPort published news for 2023 q2
SEC form 6
2023-07-12 16:31 ET
CryoPort published news for 2023 q2
SEC form 8
2023-07-12 00:00 ET
CryoPort published news for 2023 q2
SEC form 10
2023-05-04 00:00 ET
CryoPort published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
CryoPort published news for 2023 q1
SEC form 6
2023-03-28 17:15 ET
CryoPort published news for 2022 q4
SEC form 6
2023-03-15 16:31 ET
CryoPort published news for 2022 q4
SEC form 10
2023-02-28 17:08 ET
CryoPort published news for 2022 q4
SEC form 10
2023-02-28 00:00 ET
CryoPort reported for 2022 q4
SEC form 6
2023-02-23 16:47 ET
CryoPort published news for 2022 q4
SEC form 8
2023-02-23 00:00 ET
CryoPort reported for 2022 q4
SEC form 10
2022-11-04 15:14 ET
CryoPort published news for 2022 q3
SEC form 10
2022-11-04 00:00 ET
CryoPort reported for 2022 q3
SEC form 6
2022-11-03 16:30 ET
CryoPort published news for 2022 q3
SEC form 8
2022-11-03 00:00 ET
CryoPort reported for 2022 q3
SEC form 10
2022-08-04 17:04 ET
CryoPort published news for 2022 q2
SEC form 6
2022-08-04 16:31 ET
CryoPort published news for 2022 q2
SEC form 10
2022-08-04 00:00 ET
CryoPort reported for 2022 q2
SEC form 8
2022-08-04 00:00 ET
CryoPort reported for 2022 q2
SEC form 10
2022-05-05 17:02 ET
CryoPort published news for 2022 q1
SEC form 6
2022-05-05 16:26 ET
CryoPort published news for 2022 q1
SEC form 6
2022-05-05 11:49 ET
CryoPort published news for 2022 q1
SEC form 10
2022-05-05 00:00 ET
CryoPort reported for 2022 q1
SEC form 8
2022-05-05 00:00 ET
CryoPort reported for 2022 q1
SEC form 6
2022-03-21 16:30 ET
CryoPort published news for 2021 q4
SEC form 6
2022-03-18 16:59 ET
CryoPort published news for 2021 q4
SEC form 6
2022-03-11 17:28 ET
CryoPort published news for 2021 q4
SEC form 10
2022-02-28 17:24 ET
CryoPort published news for 2021 q4
SEC form 10
2022-02-28 00:00 ET
CryoPort published news for 2021 q4
SEC form 6
2022-02-24 17:31 ET
CryoPort published news for 2021 q4
SEC form 8
2022-02-24 00:00 ET
CryoPort published news for 2021 q4
SEC form 6
2022-02-09 16:32 ET
CryoPort published news for 2021 q4
SEC form 6
2022-01-31 17:44 ET
CryoPort published news for 2021 q4
SEC form 6
2021-11-12 17:10 ET
CryoPort published news for 2021 q3
SEC form 6
2021-11-10 06:06 ET
CryoPort published news for 2021 q3
SEC form 6
2021-11-08 16:44 ET
CryoPort published news for 2021 q3
SEC form 10
2021-11-04 17:12 ET
CryoPort published news for 2021 q3
SEC form 6
2021-11-04 16:53 ET
CryoPort published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
CryoPort published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
CryoPort published news for 2021 q3
SEC form 10
2021-08-06 00:00 ET
CryoPort published news for 2021 q2
SEC form 10
2021-08-05 18:42 ET
CryoPort published news for 2021 q2
SEC form 6
2021-08-05 17:07 ET
CryoPort published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
CryoPort published news for 2021 q2
SEC form 10
2021-05-06 17:11 ET
CryoPort published news for 2021 q1
SEC form 10
2021-05-06 00:00 ET
CryoPort published news for 2021 q1
SEC form 6
2021-05-05 17:23 ET
CryoPort published news for 2021 q1
SEC form 6
2021-05-04 16:43 ET
CryoPort published news for 2021 q1
SEC form 8
2021-05-04 00:00 ET
CryoPort published news for 2021 q1
SEC form 6
2021-03-16 16:45 ET
CryoPort published news for 2020 q4
SEC form 6
2021-03-03 17:08 ET
CryoPort published news for 2020 q4
SEC form 6
2021-03-01 17:21 ET
CryoPort published news for 2020 q4
SEC form 10
2021-03-01 17:09 ET
CryoPort published news for 2020 q4
SEC form 6
2021-02-08 16:26 ET
CryoPort published news for 2020 q4
SEC form 6
2021-01-25 16:51 ET
CryoPort published news for 2020 q4
SEC form 6
2021-01-20 16:44 ET
CryoPort published news for 2020 q4
SEC form 6
2021-01-19 17:09 ET
CryoPort published news for 2020 q4
SEC form 6
2021-01-19 06:09 ET
CryoPort published news for 2020 q4
SEC form 6
2020-12-14 16:01 ET
CryoPort published news for 2020 q3
SEC form 10
2020-11-06 17:19 ET
CryoPort published news for 2020 q3
SEC form 6
2020-11-05 16:31 ET
CryoPort published news for 2020 q3
SEC form 6
2020-10-01 16:15 ET
CryoPort published news for 2020 q3